MoneyWorks4Me

Ind-Swift Laboratories informs about communication to shareholders

21 Jun 2025 Evaluate

In terms of Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 and pursuant to the SEBI Master Circular no. SEBI/HO/MIRSD/POD-1/P/CIR/2024/37 dated May 07, 2024, Ind-Swift Laboratories has informed that it enclosed copy of intimation letter sent to the identified shareholders of the Company on 21st June 2025 for furnishing PAN, KYC details and Nomination details. Specimen copy of letter sent to shareholders is attached.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..